Document is current
Any future updates will be listed below
-
Authors
Castillo, Elena C. https://orcid.org/0000-0002-8799-8437
Vázquez-Garza, Eduardo https://orcid.org/0000-0001-7149-8334
Yee-Trejo, David https://orcid.org/0000-0001-5872-9230
García-Rivas, Gerardo https://orcid.org/0000-0003-4731-3293
Torre-Amione, Guillermo https://orcid.org/0000-0001-9950-0416
-
Funding
Funding for this research was provided by:
Conacyt (151136, 133591, 269399)
Conacyt MEXICO (Fronteras de la Ciencia Grant (0682))
- License Information
-
More Information
Article History
First Online: 10 September 2020
Compliance with Ethical Standards
:
: Gerardo García-Rivas and Guillermo Torre-Amione are co-founders of Nano4Heart, a start-up company focused on developing immunotherapies for the treatment of heart failure. The other authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
